While considerable advances have been made in understanding the biology and treatment of schizophrenia, patients and physicians continue to face tough challenges, says the 2015-16 winner of the University of Pennsylvania ...
May 19, 2016
0
44
(HealthDay)—For patients with relapse-onset multiple sclerosis (MS), disease-modifying therapy protects against long-term disability accrual, according to a study published online May 4 in the Annals of Neurology.
May 9, 2016
0
32
People with drug addictions who started opioid abuse later in life use injections for their drugs, or increased their use of downers before starting drug treatment, are more likely to relapse from treatment than others, says ...
Apr 13, 2016
0
8
Pregnancy does not increase the risk of relapse among women successfully treated for Hodgkin lymphoma. This according to a new study from Sweden's Karolinska Institutet and Uppsala University published in The Journal of Clinical ...
Dec 15, 2015
0
1
City academics and students from the Centre of Psychological Wellbeing and Neuroscience are collaborating with the North East London NHS Foundation Trust to see if Mindfulness Based Cognitive Therapy (MBCT) can prevent relapse ...
Nov 13, 2015
0
29
Dermal leishmaniasis is an ulcerous skin disease caused by a tropical parasite, all forms of which can be treated with the drug miltefosine. Researchers from the National Institute of Pathology, Indian Council of Medical ...
Oct 22, 2015
0
16
Scientists have developed a new test to identify patients who are at risk of suffering a relapse from testicular cancer.
Oct 15, 2015
0
7
Women with multiple sclerosis (MS) who intended to breastfeed their infants exclusively for two months had a lower risk of relapse during the first six months after giving birth compared with women who did not breastfeed ...
Aug 31, 2015
0
92
A new computational study published in the International Journal of Bioinformatics Research and Applications has shown how mutations that give rise to drug resistance occur in a form of cancer known as acute myeloid leukemia ...
Aug 4, 2015
0
7
The goal for many cancer patients is to reach the five-year, disease-free mark, but new research from UR Medicine's Wilmot Cancer Institute suggests that two years might be a more practical survival goal for people with follicular ...
Jun 29, 2015
0
14
